CORDIS · 820735 · H2020
LIBERATE Lignin Biorefinery Approach using Electrochemical Flow
Coordinator: ACONDICIONAMIENTO TARRASENSE ASSOCIACION (ES)
Liberate represents a powerhouse consortium, including three major multinational chemical companies, Evonik (EO), Perstorp (PER), Oxiris (OXI), SMEs (Chimar, Megara, NX Filtration, Condias, Enso, Idener and gate to growth), four internationally regarded research and technology organisations (ECN, Fraunhofer, Leitat and Sintef), and European leading universities (University of Mainz and University of Alicante). LIBERATE will overcome the technical developments, pilot line scale-up and commercial exploitation barriers of the next generation of biorefineries. Highly efficient and selective anodi…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €8.8M awarded to the consortium. The project runs over approximately 4.5 years from 2018-10-01 to 2023-03-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from ES
see all →- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · HORIZON · €206.9M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · H2020 · €89.8M
- DRIVER+ — DRiving InnoVation in crisis management for European Resilience607798 · FP7 · €33.5M
- READI — Research in Europe and Diversity Inclusion101166227 · HORIZON · €31.5M
- GREENH2ATLANTIC — A 100 MW FLEXIBLE GREEN HYDROGEN PRODUCTION PROCESS SOURCING HYBRID RENEWABLE ENERGY AND SUPPLYING GREEN HYDROGEN TO MULTIPLE END-USES101036908 · H2020 · €30.0M
- PERSEUS — Protection of European seas and borders through the intelligent use of surveillance261748 · FP7 · €27.8M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- HBP SGA1 — Human Brain Project Specific Grant Agreement 1720270 · CH · €89.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the IA funding scheme.
- What is the EU contribution?
- The European Commission contributes €8.8M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-NMBP-ST-IND-2018-2020.
- Who coordinates the project?
- The project is coordinated by ACONDICIONAMIENTO TARRASENSE ASSOCIACION (ES).
- What is the project timeline?
- The project runs from 2018-10-01 to 2023-03-31 — approximately 4.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 820735.